Titan Medical to Delist from TSX and Move to TSX Venture Exchange

Titan Medical plans to merge with Conavi Medical and rebrand as Conavi Medical Corp following the move.

Titan Medical's board has approved the voluntary delisting of its shares from the Toronto Stock Exchange, expected to occur between October 4 and October 10, 2024.
The company will transition its shares to the TSX Venture Exchange in connection with its planned acquisition of Conavi Medical.
The merger with Conavi Medical will result in a reverse takeover, with the combined entity being renamed Conavi Medical Corp.
Shareholders voted in favor of all management resolutions at Titan's recent Annual General and Special Meeting, including the name change and share consolidation.
The Novasight Hybrid System, developed by Conavi Medical, has received regulatory approvals from multiple countries, including the U.S., Canada, China, and Japan.